News | March 15, 2023
Philips and Gibraltar Health Authority announce 16-year strategic partnership
Patients will no longer need to travel abroad for treatment of acute cardiac diseases
Patients will no longer need to travel abroad for treatment of acute cardiac diseases
Proposed combination enhances Pfizer’s position as a leading company in oncology
ALPLA is expanding its presence in the global market for pharmaceutical packaging by establishing a joint venture with Inden Pharma
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency
For the first-line treatment of patients with unresectable advanced or metastatic malignant pleural mesothelioma
The agreement is for USFDA approved Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets
The business serves the healthcare and laboratory sectors on the west coast of the United States.
This new capability represents a significant shift from a microscope-based standard of care to the use of digital whole slide images
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
Subscribe To Our Newsletter & Stay Updated
